Dublin, Feb. 13, 2017 -- Research and Markets has announced the addition of the "Rotavirus Group A Forecast for selected Asian Markets 2017-2027" report to their offering.
Rotavirus is a contagious virus that can cause gastroenteritis (inflammation of the stomach and intestines). Symptoms include severe watery diarrhoea, often with vomiting, fever, and abdominal pain.
Rotavirus infects and damages the cells that line the small intestine, causing gastroenteritis. It is the most frequent cause of diarrhoea in young children, worldwide.
Although eight distinct groups of rotavirus have been identified (A, B, C, D, E, F, G and H), Rotavirus Group A is the most common species affecting humans. Group A rotaviruses are then typed on the basis of the variability in the genes encoding the 2 outer capsid proteins (VP7 and VP4) into 15 ""G"" and 26 ""P"" genotypes, respectively. This results in potentially > 300 different rotavirus A strains in Group A.
This report provides the current incident population for Rotavirus for Selected Asian Markets (Cambodia, Indonesia, Lao PDR and Vietnam) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team, several of the main symptoms of Rotavirus have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Rotavirus is transmitted via the faecal-oral route either by direct contact with an infected individual. According to the CDC, rotavirus can be spread by contact with contaminated:
- Hands
- Objects (toys, surfaces)
- Food
- Water
Reasons to Buy:
- Able to quantify patient populations in global Rotavirus market to target the development of future products, pricing strategies and launch plans.
- Gain further insight into the incidence of the subdivided types of Roravirus and identify patient segments with high potential.
- Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
- Identify sub-populations within Rotavirus which require treatment.
- Gain an understanding of the specific markets that have the largest number of Rotavirus patients.
Key Topics Covered:
1. Introduction
2. Cause of the Disease
3. Risk Factors & Prevention
4. Diagnosis of the Disease
5. Variation by Geography
6. Disease Prognosis & Clinical Course
7. Methodology for quantification of patient numbers
8. Top-line estimated incidence for Rotavirus
8.1 Genotype of Rotavirus A
9. Rotavirus in Vietnam
9.1 Distribution by Province within the Red River Delta area
9.2 Distribution by Province within the North Central & Central coastal areas
10. Abbreviations used in the report
11. Patient-Based Offering
12. Online Pricing Data and Platforms
13. References
14. Appendix
For more information about this report visit http://www.researchandmarkets.com/research/vk8pxv/rotavirus_group_a
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs, Gastrointestinal Drugs


SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Washington Post Publisher Will Lewis Steps Down After Layoffs
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Instagram Outage Disrupts Thousands of U.S. Users
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 



